Miklos Feher

This inventor holds 23 USPTO granted patents, plus 2 CIPO patents and 5 EPO patents, primarily in Cancer Treatment. Top assignees: University Health Network, Paloma Pharmaceuticals, Inc.. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miklos Feher. Retrieved from https://idiyas.com/inventor/miklos-feher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 91.3

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 5.8

ph-index = 9

Forward Citations = 162(Granted Patents)

Location History:

Toronto, CA (2012 - 2015)
New York, NY (US) (2015 - 2023)

Company Filing History:

21 out of 312

University Health Network

patents

1 out of 3

Paloma Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

PLK-4 Inhibitor

Pyrazolopyrimidine Compounds

Cancer Treatment

Indazole Compounds

Cellular Proliferation

Angiogenesis

PTEN Mutant Diseases

Cyclic Inhibitors

Carnitine Palmitoyltransferase

Benzimidazolyl Derivatives

Compositions

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11667627 - Salt and crystal forms of PLK-4 inhibitor (2023-06-06),

2. 10919886 - Salt and crystal forms of PLK-4 inhibitor (2021-02-16),

3. 10570143 - Pyrazolopyrimidine compounds (2020-02-25),

4. RE47731 - Kinase inhibitors and method of treating cancer with same (2019-11-18),

5. 10472353 - Salt and crystal forms of PLK-4 inhibitor (2019-11-12),

6. 10392374 - Salt and crystal forms of PLK-4 inhibitor (2019-08-27),

7. 10358436 - Kinase inhibitors and method of treating cancer (2019-07-23),

8. 10106545 - Pyrazolopyrimidine compounds (2018-10-23),

9. 9907800 - Kinase inhibitors and method of treating cancer (2018-03-06),

10. 9884855 - Salt and crystal forms of PLK-4 inhibitor (2018-02-06),

11. RE46558 - Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis (2017-09-25),

12. 9580390 - Indazole compounds as kinase inhibitors and method of treating cancer with same (2017-02-28),

13. 9573954 - Pyrazolopyrimidine compounds (2017-02-21),

14. 9402828 - Methods of targeting PTEN mutant diseases and compositions therefor (2016-08-02),

15. 9139563 - Kinase inhibitors and method of treating cancer (2015-09-22),

Title: Inventor Miklos Feher: Pioneering Innovations in New York

Introduction: Miklos Feher is a renowned inventor based in New York, NY, known for his groundbreaking contributions to various industries.

Latest Patents: Miklos Feher holds several patents in the fields of technology, healthcare, and sustainable energy, with his most recent patent focusing on advanced robotics for medical applications.

Career Highlights: Throughout his career, Miklos Feher has been recognized for his innovative solutions that have revolutionized the way industries operate. His work has significantly impacted the fields of artificial intelligence, biotechnology, and renewable energy.

Collaborations: Miklos Feher has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to market. His partnerships have led to successful commercialization of his patented technologies.

Conclusion: Miklos Feher's dedication to innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor in New York and beyond.

Profile summary based on public USPTO records.